Durable Molecular Complete Remission Induced by Low-dose Imatinib plus Low-dose Interferon Alpha in a Patient with Chronic Myelogenous Leukaemia

Author： Takeuchi J   Miura K   Hatta Y   Sawada U  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.34, Iss.1, 2006-01, pp. : 103-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-α Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia

By Reed Shelby D.   Anstrom Kevin J.   Li Yanhong   Schulman Kevin A.  

PharmacoEconomics, Vol. 26, Iss. 5, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite

Low-Dose Bezafibrate-Associated Myositis in a Patient with Chronic Renal Failure

By Gotsman I.  

Clinical Drug Investigation, Vol. 18, Iss. 6, 1999-12 ,pp. : 481-483

Adis International

Access to resources Recommend Favorite

Low-dose interferon- -1a beneficial in early MS

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Intrathecal administration of low-dose morphine plus low-dose bupivacaine provides effective postoperative analgesia

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Low-Dose Ethinylestradiol/Levonorgestrel

By Dando Toni M.   Curran Monique P.  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2299-2306

Adis International

Access to resources Recommend Favorite